Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus.
Poxviruses use an arsenal of molecular weapons to evade detection and disarm host immune responses. We used DNA microarrays to investigate the gene expression responses to infection by monkeypox virus (MPV), an emerging human pathogen, and Vaccinia virus (VAC), a widely used model and vaccine organism, in primary human macrophages, primary human fibroblasts and HeLa cells. Even as the overwhelmingly infected cells approached their demise, with extensive cytopathic changes, their gene expression programs appeared almost oblivious to poxvirus infection. Although killed (gamma-irradiated) MPV potently induced a transcriptional program characteristic of the interferon response, no such response was observed during infection with either live MPV or VAC. Moreover, while the gene expression response of infected cells to stimulation with ionomycin plus phorbol 12-myristate 13-acetate (PMA), or poly (I-C) was largely unimpaired by infection with MPV, a cluster of pro-inflammatory genes were a notable exception. Poly(I-C) induction of genes involved in alerting the innate immune system to the infectious threat, including TNF-alpha, IL-1 alpha and beta, CCL5 and IL-6, were suppressed by infection with live MPV. Thus, MPV selectively inhibits expression of genes with critical roles in cell-signaling pathways that activate innate immune responses, as part of its strategy for stealthy infection.
Departments of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, United States of America.
Kathleen H
KH
Rubins
Lisa E
LE
Hensley
David A
DA
Relman
Patrick O
PO
Brown
D006801:Humans; D002478:Cells, Cultured; D005347:Fibroblasts / Q000821:virology; D005786:Gene Expression Regulation / Q000276:immunology; D020868:Gene Silencing; D006367:HeLa Cells; D054884:Host-Pathogen Interactions / Q000276:immunology; D007113:Immunity, Innate / Q000235:genetics; D008264:Macrophages / Q000821:virology; D008993:Monkeypox virus / Q000276:immunology; D014615:Vaccinia; D014616:Vaccinia virus / Q000276:immunology; D045908:Mpox, Monkeypox
Br Med Bull. 1998;54(3):693-702
10326294
PLoS One. 2010 Mar 22;5(3):e9753
20339534
Immunol Rev. 1997 Oct;159:137-54
9416508
Mol Genet Metab. 1999 Aug;67(4):278-82
10444338
RNA. 2006 Oct;12(10):1853-67
16931877
Arch Virol Suppl. 1996;11:135-40
8800795
J Exp Med. 2005 Mar 21;201(6):1007-18
15767367
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11796-801
12195013
Science. 2000 May 5;288(5467):874-7
10797013
Virology. 1993 Jun;194(2):537-47
8099244
Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4825-9
1350676
Comp Immunol Microbiol Infect Dis. 1996 Sep;19(4):305-17
8894380
J Biol Chem. 1993 Jun 15;268(17):12837-42
8099586
J Virol. 2005 Feb;79(4):2584-96
15681458
Virology. 1998 Apr 10;243(2):406-14
9568039
J Virol. 2004 Jun;78(11):5820-34
15140980
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11513-8
20534518
Nature. 2000 Feb 3;403(6769):503-11
10676951
Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1514-8
14757814
J Virol. 1995 Aug;69(8):4633-9
7609027
In Vitro Cell Dev Biol Anim. 1995 Jun;31(6):447-55
8589888
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10162-7
10920188
J Virol. 2002 May;76(10):5251-9
11967338
J Virol. 2000 Dec;74(23):11230-9
11070021
Nature. 2000 Aug 17;406(6797):747-52
10963602
Bioinformatics. 2004 Nov 22;20(17):3246-8
15180930
Lancet Infect Dis. 2004 Jan;4(1):15-25
14720564
J Virol. 1992 Apr;66(4):1943-50
1347793
J Virol. 2001 Jan;75(2):850-6
11134298
Virology. 2002 Jun 5;297(2):172-94
12083817
J Biol Chem. 2001 Mar 23;276(12):8951-7
11124948
Virology. 1994 Jun;201(2):215-40
8184534
J Gen Virol. 1991 Jun;72 ( Pt 6):1349-76
2045793
Diabetologia. 2003 Dec;46(12):1641-57
14600816
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15196-200
15477589
J Biol Chem. 2003 Jun 27;278(26):23861-7
12676946
Virology. 1998 Oct 25;250(2):302-15
9792841
J Exp Med. 2003 Feb 3;197(3):343-51
12566418
Virol J. 2010 Jul 28;7:173
20667104
Cold Spring Harb Symp Quant Biol. 1999;64:71-8
11232339
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
9843981
PLoS One. 2008 Jul 09;3(7):e2628
18612436
FEBS Lett. 2001 Nov 30;509(1):66-70
11734207
N Engl J Med. 2004 Jan 22;350(4):342-50
14736926
Virology. 2001 Oct 25;289(2):378-87
11689059
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15190-5
15477590
Annu Rev Immunol. 2003;21:377-423
12543935
Eur J Biochem. 1997 Nov 15;250(1):85-91
9431994
Lab Invest. 2001 Dec;81(12):1581-600
11742030
Immunol Rev. 2008 Oct;225:96-113
18837778
Science. 2001 Oct 26;294(5543):870-5
11679675
Methods Enzymol. 1999;303:179-205
10349646
J Biol Chem. 1995 Jul 7;270(27):15974-8
7608155
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):972-7
11805339
Virology. 1995 Apr 20;208(2):762-9
7747448
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15623-8
9861020
Cell. 1995 May 19;81(4):551-60
7758109